These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33108111)

  • 1. Nutrition and Markers of Disease Severity in Patients With Bronchiectasis.
    Despotes KA; Choate R; Addrizzo-Harris D; Aksamit TR; Barker A; Basavaraj A; Daley CL; Eden E; DiMango A; Fennelly K; Philley J; Johnson MM; McShane PJ; Metersky ML; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL; Knowles MR; Daniels MLA; Noone PG
    Chronic Obstr Pulm Dis; 2020 Oct; 7(4):390-403. PubMed ID: 33108111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis.
    Qi Q; Li T; Li JC; Li Y
    Braz J Med Biol Res; 2015 Aug; 48(8):715-24. PubMed ID: 26176309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
    Choate R; Aksamit TR; Mannino D; Addrizzo-Harris D; Barker A; Basavaraj A; Daley CL; Daniels MLA; Eden E; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; McShane PJ; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Winthrop KL; Stone G
    Respir Med; 2021 Feb; 177():106285. PubMed ID: 33401148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
    Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
    BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Disease in Patients with Middle-Lobe Predominant Bronchiectasis.
    McDonnell MJ; Ahmed M; Das J; O'Mahony M; Breen D; O'Regan A; Gilmartin JJ; Bruzzi J; Rutherford RM
    Respiration; 2017; 93(6):406-414. PubMed ID: 28423372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.
    Aksamit TR; O'Donnell AE; Barker A; Olivier KN; Winthrop KL; Daniels MLA; Johnson M; Eden E; Griffith D; Knowles M; Metersky M; Salathe M; Thomashow B; Tino G; Turino G; Carretta B; Daley CL;
    Chest; 2017 May; 151(5):982-992. PubMed ID: 27889361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of concomitant nontuberculous mycobacteria and
    Hsieh MH; Lin CY; Wang CY; Fang YF; Lo YL; Lin SM; Lin HC
    Infect Drug Resist; 2018; 11():1137-1143. PubMed ID: 30127630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between weight and pulmonary outcomes in overweight and obese people with cystic fibrosis: A retrospective observational study.
    Welter JJ; Lennox AT; Krishnan S; Kim C; Krishnan S; Thompson H; McAllister E; Huang K; Nwaedozie K; Dozor AJ
    Health Sci Rep; 2022 Nov; 5(6):e910. PubMed ID: 36320654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between bronchiectasis exacerbations and longitudinal changes in FEV
    Aksamit TR; Lapinel NC; Choate R; Feliciano J; Winthrop KL; Schmid A; Wu J; Fucile S; Metersky ML;
    Respir Med; 2024 Jul; 228():107660. PubMed ID: 38734153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Body Mass Index on Outcomes After Hip Arthroscopic Surgery With Capsular Plication for the Treatment of Femoroacetabular Impingement.
    Saltzman BM; Kuhns BD; Basques B; Leroux T; Alter J; Mather RC; Salata MJ; Nho SJ
    Am J Sports Med; 2017 Aug; 45(10):2303-2311. PubMed ID: 28520460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of body mass index on long-term outcomes in Japanese patients following percutaneous coronary intervention: The Juntendo PCI Registry.
    Endo H; Dohi T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    J Cardiol; 2018 Sep; 72(3):208-214. PubMed ID: 29550145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
    Mirsaeidi M; Hadid W; Ericsoussi B; Rodgers D; Sadikot RT
    Int J Infect Dis; 2013 Nov; 17(11):e1000-4. PubMed ID: 23683809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between peak oxygen uptake, lung function, and bronchiectasis in children with cystic fibrosis in the era of CFTR modulators.
    Du Berry C; Westrupp N; Shanthikumar S; Welsh L
    Pediatr Pulmonol; 2021 Jun; 56(6):1490-1495. PubMed ID: 33458944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.
    Eden E; Choate R; Barker A; Addrizzo-Harris D; Aksamit TR; Daley CL; Daniels MLA; DiMango A; Fennelly K; Griffith DE; Johnson MM; Knowles MR; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Salathe MA; Schmid A; Thomashow B; Tino G; Turino GM; Winthrop KL
    Chronic Obstr Pulm Dis; 2019 Apr; 6(2):145-153. PubMed ID: 30974050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
    Li L; Liu Y; Li J; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study.
    Fong I; Low TB; Yii A
    Chron Respir Dis; 2022; 19():14799731221098714. PubMed ID: 35471849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do acute hospitalised patients in Australia have a different body mass index to the general Australian population: a point prevalence study?
    Dennis DM; Carter V; Trevenen M; Tyler J; Perrella L; Lori E; Cooper I
    Aust Health Rev; 2018 Apr; 42(2):121-129. PubMed ID: 28225703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and ethnic differences in patients enrolled in the national bronchiectasis and nontuberculous mycobacteria research registry.
    McShane PJ; Choate R; Johnson M; Maselli DJ; Winthrop KL; Metersky ML;
    Respir Med; 2023 Apr; 209():107167. PubMed ID: 36804343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.